financetom
Business
financetom
/
Business
/
--Allete Keeps Quarterly Dividend at $0.705 a Share, Payable Dec. 1 to Shareholders of Record on Nov. 15
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Allete Keeps Quarterly Dividend at $0.705 a Share, Payable Dec. 1 to Shareholders of Record on Nov. 15
Nov 3, 2024 11:58 AM

04:50 PM EDT, 10/25/2024 (MT Newswires) --

Price: 64.30, Change: -0.03, Percent Change: -0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EZCORP Prices $300 Million Senior Notes Offering
EZCORP Prices $300 Million Senior Notes Offering
Mar 25, 2025
04:34 AM EDT, 03/25/2025 (MT Newswires) -- EZCORP ( EZPW ) said late Monday it priced a private offering of $300 million of senior notes due 2032, with an interest rate of 7.375% per year. The offering is set to close on Friday, subject to customary conditions, the company said. The net proceeds are expected to be approximately $292.5 million....
Interparfums Insider Sold Shares Worth $2,934,603, According to a Recent SEC Filing
Interparfums Insider Sold Shares Worth $2,934,603, According to a Recent SEC Filing
Mar 25, 2025
04:28 AM EDT, 03/25/2025 (MT Newswires) -- Philippe Benacin, 10% Owner, Director, President Interparfums, on March 21, 2025, sold 25,000 shares in Interparfums (IPAR) for $2,934,603. Following the Form 4 filing with the SEC, Benacin has control over a total of 6,846,064 common shares of the company, with 6,846,064 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/822663/000175392625000479/xslF345X05/primary_doc.xml ...
Alumis, Kaken Pharmaceutical Enter Collaboration, Licensing Deal for Dermatology Drug
Alumis, Kaken Pharmaceutical Enter Collaboration, Licensing Deal for Dermatology Drug
Mar 25, 2025
04:28 AM EDT, 03/25/2025 (MT Newswires) -- Alumis ( ALMS ) and Kaken Pharmaceutical have struck a collaboration and licensing agreement to develop, manufacture and commercialize ESK-001 for dermatology indications in Japan, with an option to expand the license to include rheumatological and gastrointestinal diseases, the companies said Tuesday. Under the terms of the agreement, Alumis ( ALMS ) will...
BlackRock launches first bitcoin product in Europe
BlackRock launches first bitcoin product in Europe
Mar 25, 2025
LONDON, March 25 (Reuters) - BlackRock ( BLK ) has launched its first bitcoin exchange-traded product in Europe, in a bid to tap growing demand for cryptocurrency exposure in new markets after attracting more than $50 billion into similar products in the United States. The world's largest asset manager has launched its 'iShares Bitcoin ETP', according to a BlackRock (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved